Sight Sciences, Inc. - Common Stock (SGHT)
4.6900
+1.2400 (35.94%)
NASDAQ · Last Trade: Oct 19th, 8:29 AM EDT
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
Via Chartmill · October 17, 2025
Via Benzinga · October 17, 2025
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · October 17, 2025

Via Benzinga · January 15, 2025
Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.
Via Chartmill · October 17, 2025
UnitedHealthcare's new policy covers implant-free glaucoma surgeries like OMNI, supporting treatment for mild to moderate open-angle glaucoma and cataracts.
Via Benzinga · September 9, 2025
Via Benzinga · July 15, 2025
Wondering what's happening in Monday's pre-market session? Find an overview in this article.
Via Chartmill · April 28, 2025
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · April 2, 2025

Via Benzinga · November 5, 2024

SGHT stock results show that Sight Sciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 2, 2024

Pre-market stock movers are a hot topic this morning as we check out all of the biggest news worth reading about on Wednesday morning!
Via InvestorPlace · April 3, 2024

Via Benzinga · April 2, 2024

SGHT stock results show that Sight Sciences beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 7, 2024

Via Benzinga · January 24, 2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via Benzinga · March 7, 2024